Press Release: 27 July 2014
Bionorica: Russian junior scientists wins German research prize in
herbal medicines field
Majorca, Spain / Moscow & Perm, Russia: “I value this honour
because we can now commence our laboratory investigations of
endometrial cells and the effects of various botanical substances on
the uterus”, rejoices Dr Anastasia Savilova from the State Research
Centre for Obstetrics, Gynaecology and Perinatology in Moscow.
Dr. Quave is one of 20 winners at the Global Research Initiative
(GRI), which was honored by the Executive Board of German herbal
medicines specialist Bionorica at the end of 2013. “I am pleased that
so many innovative and promising entries were submitted. Such a
large and high-quality response to the first-time call for submissions proves that herbal
medicine is gaining further relevance among the scientific community as well,” says Dr.
Michael Popp, CEO and owner of the internationally successful manufacturer of
scientifically researched herbal medicines, German-based Bionorica SE.
Dr. Popp will pay out a total of one million euros for the unique herbal medicine research
campaign. He is expecting that the 20 prizes of EUR 50,000 each for research will result in
new stimulus for the field of herbal medicine to be able to offer patients an even greater
variety of products. “In addition to new analysis processes, the focus is also the search for
innovative approaches to new development of herbal medicines,” says pharmacist Dr.
Popp.
Price winner Dr Svetlana A.
Kalinina from Pharmaceuticals
Academy Perm
The two Russian prize-winners have chosen very different fields of activity. In her study,
Dr Anastasia Savilova would like be the first to investigate the interaction of a specific
botanical medication with uterine cells.
By contrast, her Russian colleague, Dr Svetlana A. Kalinina, also
awarded the prize, is engaged in testing a completely new
botanical extract. “This award could be the crucial step for me in
the development of an extract as a medication for the treatment
of coagulation disorders, high blood pressure and renal diseases”,
according to the researcher from the Pharmaceuticals Academy in
Perm at the award presentation ceremony.
The 20 prize winners from 13 nations received their awards on
Sunday, 27 July 2014, within the scope of the international symposium “Inflammations –
Challenges and Opportunities” at the Bionorica Herbal Medicines Competence Center
Price winner Dr Anastasia
Savilova from State
Research Centre in Moscow
World market leader in herbal medicines awards the sum of EUR 1 million to 20
international prize winners for excellent research projects.
Sa Canova in Sa Pobla, Mallorca. The jury reviewed
some 130 submissions from various treatment fields,
including
respiratory
diseases,
osteoporosis,
gynecological diseases, bladder cancer and Alzheimer’s
disease, among others. In addition, ideas for research
methods and technologies were also honored.
Bionorica is a manufacturer of herbal medicines and is
active in some 50 countries. With its unique quality
concept and its focus on consistent standardization of
cultivation and production, Bionorica has been able to
grow into a worldwide leading company in the
promising sector of herbal medicines in the past 15
years.
Media contact:
Thomas Eibenberger
Senior Referent Corporate Communications
Tel.: +49 9181 231-450
thomas.eibenberger@bionorica.de
Press kit and additional images available at:
www.bionorica.de/research.initiative2013.
-2-
Global Research Award 2013/14
All 20 prize winners according to category
Group 1: Respiratory System
Rebecca Clarke, Queens University Belfast, Ireland, for a novel human in-vitro model to
study modulatory properties of plant-based medicines.
Dr. Claudina Perez Novo, University Hospital Ghent, Belgium, for analysis of the
molecular mechanisms involved in the anti-inflammatory action of an herbal preparation
on chronic rhinosinusitis.
Dr. Laura Sadofsky, University of Hull, England, for researching the effect of the natural
agonists and antagonists of the airway irritant receptors in vitro.
Prof. Adil Katarbayev, Kazakh State Medical University in Almaty, Kazakhstan, for
Preclinical studies of an herbal preparation in acute intestinal infection.
Dr. Diana Zabolotnaya, National Academy of Medical Sciences, Kiev, Ukraine, for a study
of an adjuvant effect of phyto products on antibody formation against influenza virus
antigens in experimental animals.
Group 2: Gynaecology / Osteoporosis
Dr. Annekathrin Keiler and Dr. Oliver Zierau, Technical University Dresden, Germany,
for researching the effects of a hops extract on osteoporosis in a rat model.
Dr. Anastasia Savilova, Moscow State University, Russia, for an investigation the
mechanism of action of an herbal preparation on endometrial mesenchymal stromal cells.
Dr. Petra Stute, Inselspital Bern, Switzerland, for researching the impact of black cohosh
on hippocampal and hypothalamic gene expression profiles in ovariectomized rats.
Group 3: Other Indications
Dr. Johanna Brandner, University Hospital Hamburg-Eppendorf, Germany, for a study on
the Effects of Arnebia euchroma extracts on different stages of wound healing.
Dr. Temuujin Dansranjavin, University of Giessen, Germany, for the Characterization of
the epigenetic regulation in prostatitis and prostate cancer by an herbal preparation.
Dr. Svetlana Kalinina, Perm State Pharmaceutical Academy, Russia, for researching
Verbascum nigrum extract as a new complex phytotherapeutic agent.
Dr. Markus Krohn, University of Magdeburg, Germany, for Defining specific extracts from
St. John’s Wort for the treatment of Alzheimer’s disease.
Dr. Cassandra Leah Quave, Emory University Atlanta, USA, for a study on Botanical
natural product inhibitors of acne biofilms.
-3-
Dr. Miroslaw Szczepanski, Medical University of Warsaw, Poland, for Researching anticancer effect of an herbal preparation in head and neck squamous cell carcinoma.
Group 4: Optimisation, New Technologies and Targets
Dr. Camilla Bergonzi, University of Florence, Italy, for Innovative formulations to
enhance oral bioavailability of herbal extracts.
Dr. Andreas Köberle, University of Jena, Germany, for Targeting of bioactive lipid
networks: a novel pharmacological strategy for anti-inflammatory phytomedicine.
Dr. Birgit Kraus, University of Regensburg, Germany, for Correlating the structure of
differently substituted chalcones with transcriptome data and bioactivity in liver cells.
Dr. Denisa Margina, University of medicine and pharmacy Bucharest, Rumania, for
Studies on certain biological effects of encapsulated vegetal extracts with known cardiovascular positive outcome.
Dr. Stefan Schwaiger, University of Innsbruck, Austria, for researching Natural products
with effects on the NPS/NPSR system.
Dr. Jens Wild, University of Regensburg, Germany, for researching Bactericidal/
permeability-increasing protein as potential new target for antimicrobial and
immunomodulatory activities.
Service:
You can find images of the prize winners, brief CVs, abstracts of the selected projects and
photos of the awards ceremony at: www.bionorica.de/research.initiative2013
Media contact:
Thomas Eibenberger
Senior Referent Corporate Communications
Tel.: +49 9181 231-450
thomas.eibenberger@bionorica.de
-4-